N/A N=183 Management of Myelomeningocele Study (MOMS)
Meningomyelocele · Spinal Dysraphism
Primary: Infant Death or Need for Ventricular Shunt by 1 Year of Life — 66; 90 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=3 Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study
Spina Bifida · Myelomeningocele · Neural Tube Defects
Primary: Maternal Adverse Events — 2 participants
N/A N=3 Spinal Cord Stimulation in Spinal Muscular Atrophy
Spinal Muscular Atrophy Type 3 · Spinal Muscular Atrophy Type 4
Primary: Muscle Weakness — 2; 3 Participants
N/A N=6 The Effect of FES on Children With Spinal Cord Injury
Spinal Cord Injury
Primary: Change in Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0)Score. — 7.08 units on a scale
N/A N=17 Palliative Strategies in Spinal Cord Injury (SCI)
Spinal Cord Injury
Primary: Muscle Mass Via Dual-Energy X-ray Absortiometry (DEXA)Scan Data — 6104.45; 6355.3 grams — p=.318
Phase 3 N=212 Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Spinal Cord Injury · Muscle Spasticity
Primary: Double-blind Change From Baseline in Ashworth Score Evaluating Spasticity — -0.19; -0.15 units on a scale
Phase 1 N=23 Spinal Excitation to Enhance Mobility
Aging
Primary: Walking Speed Change From Baseline — .054; .078; .085; .039 meters/second
Phase 3 N=204 Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury
Spinal Cord Injury · Muscle Spasticity
Primary: Double-blind Change From Baseline in Ashworth Score Evaluating Spasticity — -0.28; -0.16 units on a scale